Giulia Lestini

1PUBLICATIONS
9CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 18, 2024
First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor.

Ewa Gatlik, Beata Mehes, Emilie Voltz

Pageof 1

Frequent Collaborators

1 joint publications

Ewa Gatlik

1 joint publications

Emilie Voltz

1 joint publications

Ulrike Sommer

1 joint publications

Elaine Tritto

1 joint publications

Parasar Pal

1 joint publications

Maria Velinova

1 joint publications

Wiliam S Denney

1 joint publications

Yunlin Fu

1 joint publications

Guido Junge

Frequent Collaborators

1 joint publications

Ewa Gatlik

1 joint publications

Emilie Voltz

1 joint publications

Ulrike Sommer

1 joint publications

Elaine Tritto

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

<em>In Vitro</em> Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
08:15

<em>In Vitro</em> Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on : Dec 09, 2022

1.8K
See more related videos

Top Related Videos

<em>In Vitro</em> Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
08:15

<em>In Vitro</em> Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on : Dec 09, 2022

1.8K
See more related videos